Which drug for which orthostatic hypotension?
Authors:
- 6 May 1996
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 10 (3) , 225-233
Abstract
Summary— This review focuses on the actual limits of the clinical pharmacology of drugs used for the treatment of orthostatic hypotension. The evidences for heterogeneity of the pathophysiological mechanisms of primary orthostatic hypotension and autonomic failure are discussed. The available data on the efficacy of some drugs used in orthostatic hypotension are also discussed.Keywords
This publication has 94 references indexed in Scilit:
- The Anemia of Primary Autonomic Failure and its Reversal with Recombinant ErythropoietinAnnals of Internal Medicine, 1994
- Loss of osmotic thirst in multiple system atrophy: association with sinoaortic baroreceptor deafferentationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1994
- Manipulation of Norepinephrine Metabolism with Yohimbine in the Treatment of Autonomic FailureThe Journal of Clinical Pharmacology, 1994
- Beta‐receptor sensitivity in autonomic failureNeurology, 1991
- Pressor effect of inhaled ergotamine in orthostatic hypotensionThe American Journal of Cardiology, 1990
- Treatment of Postural Hypotension A ReviewDrugs, 1990
- The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Metoclopramide alone or combined with flurbiprofen in the treatment of orthostatic hypotension associated with diabetes mellitusJournal of Molecular Medicine, 1982
- β‐receptor numbers and thermodynamics in denervation supersensitivityThe Journal of Physiology, 1981
- Postural hypotensionAmerican Heart Journal, 1925